Prelude Capital Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
NAMA
Prelude Capital Management's VCYT Position: Q2 2021 in Review
Prelude Capital Management sold out of Veracyte (VCYT) in Q2 2021, closing a stake of 7,239 shares — an estimated $389K sold.
Prelude Capital Management first reported a position in VCYT in Q1 2017 and held it in 12 quarters. The position peaked at $4.97M in Q1 2019. 214 funds tracked by Wall St. Rank hold VCYT as of Q2 2021.
- Prelude Capital Management reported no remaining Veracyte position as of Q2 2021 after selling out during the quarter.
- Prelude Capital Management sold 7,239 Veracyte shares in Q2 2021, an estimated $389K.
- Prelude Capital Management first reported a position in Veracyte in Q1 2017 and held it in 12 quarters.
- Prelude Capital Management's Veracyte position peaked at $4.97M in Q1 2019.
- 214 funds tracked by Wall St. Rank held Veracyte as of Q2 2021.
Based on Prelude Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.